BCAXBicara Therapeutics Inc.
$17.04-8.8% 1Y
$17.04
$13.9352 weeks$30.39
Is the business good?
How good a business is BCAX?
- Share count, year on year
- +25%
Share count, year on year · shareholders own a smaller slice than a year ago
Details›
- Free cash flow, trailing twelve months
- −$135M
- Net income, trailing twelve months
- −$185M
Margins, capital and share counts from the statements as filed with the SEC; cash conversion is operating cash flow over operating profit after tax.
On our screens:Most shorted stocks
Biotechnology
The closest names by size in the same industry